Rimini Street, Inc.

For the period ended Sep 30, 2026. Filed Oct 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 29, 2026

RMNI$5.53+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

ITEM 1. Financial Statements

Unaudited Condensed Consolidated Balance Sheets

(In thousands, except per share amounts)

	September 30,	December 31,
	2026	2025
ASSETS
Current assets:
Cash and cash equivalents	$93,321	$119,974
Restricted cash, current	343	341
Accounts receivable, net of allowance of $2,129 and $1,443, respectively	89,094	136,866
Deferred contract costs, current	17,689	17,734
Prepaid expenses and other	30,363	25,447
Total current assets	230,810	300,362
Long-term assets:
Restricted cash, noncurrent	1,004	785
Property and equipment, net of accumulated depreciation and amortization of $25,597 and $23,822, respectively	11,453	10,239
Operating lease right-of-use assets	19,900	21,371
Deferred contract costs, noncurrent	24,247	24,436
Deposits and other	9,387	8,379
Deferred income taxes, net	57,645	57,540
Total assets	$354,446	$423,112
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Current maturities of long-term debt	$—	$4,031
Accounts payable	5,912	5,752
Accrued compensation, benefits and commissions	36,100	39,609
Other accrued liabilities	24,702	24,307
Operating lease liabilities, current	4,116	4,984
Deferred revenue, current	210,775	268,717
Total current liabilities	281,605	347,400
Long-term liabilities:
Long-term debt, net of current maturities	41,741	63,156
Deferred revenue, noncurrent	24,750	18,824
Operating lease liabilities, noncurrent	16,481	18,843
Other long-term liabilities	1,393	1,918
Total liabilities	365,970	450,141
Commitments and contingencies (Note 8)
Stockholders’ deficit:
Preferred stock; $0.0001 par value. Authorized 99,820 (excluding 180 shares of Series A Preferred Stock); no other series has been designated	—	—
Common stock; $0.0001 par value. Authorized 1,000,000 shares; issued and outstanding 92,674 and 91,603 shares, respectively	9	9
Additional paid-in capital	184,802	181,075
Accumulated other comprehensive loss	(4,116)	(5,613)
Accumulated deficit	(191,103)	(201,384)
Treasury stock, at cost; 137 and 137 shares, respectively	(1,116)	(1,116)
Total stockholders' deficit	(11,524)	(27,029)
Total liabilities and stockholders' deficit	$354,446	$423,112

Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income

(In thousands, except per share amounts)

	Three Months EndedSeptember 30,		Nine Months EndedSeptember 30,
	2026	2025	2026	2025
Revenue	$112,056	$103,428	$328,604	$311,746
Cost of revenue	43,264	41,490	129,850	123,421
Gross profit	68,792	61,938	198,754	188,325
Operating expenses:
Sales and marketing	39,049	37,939	120,428	110,214
General and administrative	16,774	18,241	51,925	52,617
Research and development	1,178	—	2,863	—
Reorganization costs	1,944	752	2,517	1,936
Litigation costs and related recoveries:
Litigation settlement	—	—	—	(36,196)
Professional fees and other costs of litigation	—	621	—	4,810
Litigation costs and related recoveries, net	—	621	—	(31,386)
Total operating expenses	58,945	57,553	177,733	133,381
Operating income	9,847	4,385	21,021	54,944
Non-operating income and (expenses):
Interest expense	(980)	(1,446)	(3,361)	(4,750)
Other income (expenses), net	1,060	531	(464)	1,686
Income before income taxes	9,927	3,470	17,196	51,880
Income taxes	(3,405)	(704)	(6,915)	(15,506)
Net income	6,522	2,766	10,281	36,374
Other comprehensive income
Foreign currency translation gain (loss)	449	(329)	261	2,575
Derivative instrument and other adjustments, net of tax	278	247	1,236	(1,439)
Comprehensive income	$7,249	$2,684	$11,778	$37,510
Net income per share attributable to common stockholders:
Basic	$0.07	$0.03	$0.11	$0.40
Diluted	$0.07	$0.03	$0.11	$0.39
Weighted average number of shares of Common Stock outstanding:
Basic	93,051	92,177	92,596	91,851
Diluted	96,112	95,291	95,148	94,333

Unaudited Condensed Consolidated Statements of Stockholders' Deficit

	Three Months Ended September 30,		Nine Months EndedSeptember 30,
	2026	2025	2026	2025
Common Stock, Shares
Beginning of period	93,336	92,504	91,603	91,120
Exercise of stock options for cash	199	18	387	22
Restricted and performance stock units vested	110	88	1,655	1,468
Retired shares of Common Stock	(971)	(891)	(971)	(891)
End of period	92,674	91,719	92,674	91,719
Total Stockholders' Deficit, beginning of period	$(16,668)	$(29,035)	$(27,029)	$(69,445)
Common Stock, Amount
Beginning of period	9	9	9	9
Exercise of stock options for cash	—	—	—	—
Restricted and performance stock units vested	—	—	—	—
Retired shares of Common Stock	—	—	—	—
End of period	9	9	9	9
Additional Paid-in Capital
Beginning of period	186,907	183,117	181,075	177,533
Stock-based compensation expense	2,168	2,786	7,490	8,361
Exercise of stock options for cash	731	49	1,241	58
Restricted and performance stock units vested	—	—	—	—
Retired shares of Common Stock	(5,004)	(3,767)	(5,004)	(3,767)
End of period	184,802	182,185	184,802	182,185
Accumulated Other Comprehensive Loss
Beginning of period	(4,843)	(6,171)	(5,613)	(7,389)
Other comprehensive income (loss)	727	(82)	1,497	1,136
End of period	(4,116)	(6,253)	(4,116)	(6,253)
Accumulated Deficit
Beginning of period	(197,625)	(204,874)	(201,384)	(238,482)
Net income	6,522	2,766	10,281	36,374
End of period	(191,103)	(202,108)	(191,103)	(202,108)
Treasury Stock	(1,116)	(1,116)	(1,116)	(1,116)
Total Stockholders' Deficit, end of period	$(11,524)	$(27,283)	$(11,524)	$(27,283)

Unaudited Condensed Consolidated Statements of Cash Flows

	Nine Months Ended September 30,
	2026	2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$10,281	$36,374
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	7,490	8,361
Depreciation and amortization	3,016	2,839
Accretion and amortization of debt discount and issuance costs	491	491
Deferred income taxes	(349)	9,708
Amortization and accretion related to operating right-of-use assets	4,105	3,697
Other	39	26
Changes in operating assets and liabilities:
Accounts receivable, net	48,537	50,301
Prepaid expenses, deposits and other	(4,275)	(6,898)
Deferred contract costs	234	319
Accounts payable	137	(653)
Accrued compensation and other accruals	(9,068)	(4,297)
Deferred revenue	(52,961)	(59,609)
Net cash provided by operating activities	7,677	40,659
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(4,194)	(3,865)
Net cash used in investing activities	(4,194)	(3,865)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on revolving line of credit borrowings	—	(15,000)
Principal payments on term loan borrowings	(25,938)	(2,813)
Payments to repurchase and retire Common Stock	(5,004)	(3,767)
Principal payments on capital leases	—	(289)
Proceeds from exercise of employee stock options	1,241	59
Net cash used in financing activities	(29,701)	(21,810)
Effect of foreign currency translation changes	(214)	5,720
Net change in cash, cash equivalents and restricted cash	(26,432)	20,704
Cash, cash equivalents and restricted cash at beginning of period	121,100	89,222
Cash, cash equivalents and restricted cash at end of period	$94,668	$109,926

Unaudited Condensed Consolidated Statements of Cash Flows, Continued

	Nine Months Ended September 30,
	2026	2025
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	$2,813	$4,286
Cash paid for income taxes	3,484	3,203
Cash paid for withholding taxes	3,512	2,391
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Increase in payables for capital expenditures	$20	$—

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.